顧みられない熱帯病診断市場：サービス、疾患、診断方法、最終用途別-2025-2030年の世界予測

顧みられない熱帯病診断市場の2023年の市場規模は66億9,000万米ドルで、2024年には70億4,000万米ドルに達すると予測され、CAGR 5.80％で成長し、2030年には99億3,000万米ドルに達すると予測されています。

顧みられない熱帯病（Neglected Tropical Diseases：NTDs）には、主に熱帯・亜熱帯地域で10億人以上が罹患している多様な感染症が含まれます。NTDsは、貧困にあえぐ人々への影響によって定義され、経済発展や社会の発展を大きく妨げています。NTDの正確な診断の必要性は、これらの疾病が慢性的な健康問題、衰弱させる感染症、社会的なスティグマの原因となることを裏付けています。その用途は、基本的な診断ツールから先進的な分子解析手法まで多岐にわたり、疾病サーベイランス、効果的な治療計画、トランスミッションの削減に不可欠です。最終用途分野には、病院、診断研究所、研究機関などがあり、これらの機関はこれらの診断を利用して、集団発生を管理し、ヘルスケア政策を導き、疫学調査を実施します。NTD診断の市場成長は、世界の保健資金の増加、意識の高まり、診断技術の技術的進歩によってもたらされます。早期発見、正確な診断、費用対効果の高い解決策を重視する官民パートナーシップや世界保健イニシアティブの増加が、市場拡大の機会をもたらしています。主な成長要因としては、政府や非政府機関の投資の増加、分子検査やポイントオブケア検査のような診断技術の革新、NTDsに罹患している地域におけるヘルスケアへのアクセス拡大などが挙げられます。しかし、市場の課題としては、流行地域における不十分なヘルスケアインフラ、限られた認識、規制上の障壁、高度な診断ツールの高コストなどが挙げられます。NTDsのための低コストで迅速な診断検査、特に低資源環境でも実施可能な診断検査の開発には機会があります。技術革新は、迅速かつ正確な結果を提供する携帯可能で統合的な診断プラットフォームに集中することができ、データの普及と管理のためのデジタルヘルス技術によって補強される可能性もあります。このようなビジネスチャンスを生かすために、企業は政府やNGOとの戦略的提携に注力し、新規診断薬の研究開発に投資し、スケーラブルな生産技術に取り組むべきです。この市場で持続的に成長するためには、厳しい規制環境を乗り切り、ヘルスケア提供の障壁に対処するためのデューデリジェンスを実行する必要があります。

市場力学：急速に進化する顧みられない熱帯病診断市場の主要市場インサイトを公開

顧みられない熱帯病診断市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 顧みられない熱帯病に取り組むプログラムの増加
  • 熱帯・亜熱帯諸国における顧みられない熱帯病の有病率の上昇
  • 疾患の早期発見に対する需要の高まり
• 市場抑制要因
  • 低開発国における顧みられない熱帯病に対する治療意識の欠如
• 市場機会
  • 高度な顧みられない熱帯病診断機器の開発の高まり
  • 革新的な顧みられない熱帯病診断法を開発するための研究開発の活発化
• 市場の課題
  • 診断のための標準化ツールの欠如

ポーターのファイブフォース：顧みられない熱帯病診断市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：顧みられない熱帯病診断市場における外部からの影響の把握

外部マクロ環境要因は、顧みられない熱帯病診断市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析顧みられない熱帯病診断市場における競合情勢の把握

顧みられない熱帯病診断市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的な意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス顧みられない熱帯病診断市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、顧みられない熱帯病診断市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨顧みられない熱帯病診断市場における成功への道筋を描く

顧みられない熱帯病診断市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 顧みられない熱帯病に取り組むプログラムの増加
    • 熱帯・亜熱帯諸国における無視されがちな熱帯病の蔓延率の上昇
    • 病気の早期発見に対する需要の高まり
  • 抑制要因
    • 発展途上国における顧みられない熱帯病の治療認識の欠如
  • 機会
    • 先進的な顧みられない熱帯病診断装置の開発が進む
    • 革新的な無視される熱帯病の診断法を開発するための研究開発の高まり
  • 課題
    • 診断のための標準化ツールの欠如
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 顧みられない熱帯病診断市場：サービス別

• 集中サービス
• POCサービス

第7章 顧みられない熱帯病診断市場：疾患別

• アフリカ睡眠病
• ブルーリ潰瘍
• シャーガス病
• チクングニア熱
• デング熱
• メジナ虫症
• エキノコックス症
• 食中毒菌
• リーシュマニア症
• ハンセン病
• リンパ系フィラリア症
• オンコセルカ症
• 狂犬病
• 疥癬
• 住血吸虫症
• ヘビに噛まれて毒に侵される
• 土壌伝播性蠕虫感染症
• 条虫症/嚢虫症
• イチゴ腫

第8章 顧みられない熱帯病診断市場診断方法別

• 従来の方法
• 分子/現代的方法

第9章 顧みられない熱帯病診断市場：最終用途別

• 臨床検査室
• 在宅ヘルスケア
• 病院/クリニック

第10章 南北アメリカの顧みられない熱帯病診断市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域の顧みられない熱帯病診断市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカの顧みられない熱帯病診断市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Abbott Laboratories
• Bio-Rad Laboratories, Inc.
• Coris BioConcept SPRL
• DiaSys Diagnostic Systems GmbH
• F. Hoffmann-La Roche Ltd
• Genome Diagnostics Pvt. Ltd.
• InBios International, Inc.
• Omega Diagnostics Group PLC
• Ortho Clinical Diagnostics
• Oscar Medicare Pvt. Ltd.
• Premier Medical Corporation Ltd.
• Siemens AG
• Thermo Fisher Scientific Inc.
• ZeptoMetrix LLC

LIST OF FIGURES

• FIGURE 1. NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET RESEARCH PROCESS
• FIGURE 2. NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. AMERICAS NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 17. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. ASIA-PACIFIC NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 23. NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET DYNAMICS
• TABLE 7. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY CENTRALIZED SERVICE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY POC SERVICE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY AFRICAN TRYPANOSOMIASIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY BURULI ULCER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY CHAGAS DISEASE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY CHIKUNGUNYA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DENGUE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DRACUNCULIASIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY ECHINOCOCCOSIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY FOODBORNE TREMATODIASES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY LEISHMANIASIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY LEPROSY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY LYMPHATIC FILARIASIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY ONCHOCERCIASIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY RABIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SCABIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SCHISTOSOMIASIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SNAKEBITE ENVENOMING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SOIL-TRANSMITTED HELMINTH INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY TAENIASIS/CYSTICERCOSIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY YAWS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY CONVENTIONAL METHOD, BY REGION, 2018-2030 (USD MILLION)
• TABLE 32. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY MOLECULAR/MODERN METHOD, BY REGION, 2018-2030 (USD MILLION)
• TABLE 33. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 34. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY CLINICAL LABS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 35. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 36. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY HOSPITALS /CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 37. AMERICAS NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 38. AMERICAS NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 39. AMERICAS NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
• TABLE 40. AMERICAS NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 41. AMERICAS NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 42. ARGENTINA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 43. ARGENTINA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 44. ARGENTINA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
• TABLE 45. ARGENTINA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 46. BRAZIL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 47. BRAZIL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 48. BRAZIL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
• TABLE 49. BRAZIL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 50. CANADA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 51. CANADA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 52. CANADA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
• TABLE 53. CANADA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 54. MEXICO NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 55. MEXICO NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 56. MEXICO NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
• TABLE 57. MEXICO NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 58. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 59. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 60. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
• TABLE 61. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 62. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 63. ASIA-PACIFIC NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 64. ASIA-PACIFIC NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 65. ASIA-PACIFIC NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
• TABLE 66. ASIA-PACIFIC NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 67. ASIA-PACIFIC NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 68. AUSTRALIA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 69. AUSTRALIA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 70. AUSTRALIA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
• TABLE 71. AUSTRALIA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 72. CHINA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 73. CHINA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 74. CHINA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
• TABLE 75. CHINA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 76. INDIA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 77. INDIA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 78. INDIA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
• TABLE 79. INDIA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 80. INDONESIA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 81. INDONESIA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 82. INDONESIA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
• TABLE 83. INDONESIA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 84. JAPAN NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 85. JAPAN NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 86. JAPAN NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
• TABLE 87. JAPAN NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 88. MALAYSIA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 89. MALAYSIA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 90. MALAYSIA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
• TABLE 91. MALAYSIA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 92. PHILIPPINES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 93. PHILIPPINES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 94. PHILIPPINES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
• TABLE 95. PHILIPPINES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 96. SINGAPORE NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 97. SINGAPORE NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 98. SINGAPORE NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
• TABLE 99. SINGAPORE NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 100. SOUTH KOREA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 101. SOUTH KOREA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 102. SOUTH KOREA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
• TABLE 103. SOUTH KOREA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 104. TAIWAN NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 105. TAIWAN NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 106. TAIWAN NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
• TABLE 107. TAIWAN NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 108. THAILAND NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 109. THAILAND NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 110. THAILAND NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
• TABLE 111. THAILAND NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 112. VIETNAM NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 113. VIETNAM NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 114. VIETNAM NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
• TABLE 115. VIETNAM NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 116. EUROPE, MIDDLE EAST & AFRICA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 117. EUROPE, MIDDLE EAST & AFRICA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 118. EUROPE, MIDDLE EAST & AFRICA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
• TABLE 119. EUROPE, MIDDLE EAST & AFRICA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 120. EUROPE, MIDDLE EAST & AFRICA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 121. DENMARK NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 122. DENMARK NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 123. DENMARK NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
• TABLE 124. DENMARK NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 125. EGYPT NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 126. EGYPT NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 127. EGYPT NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
• TABLE 128. EGYPT NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 129. FINLAND NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 130. FINLAND NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 131. FINLAND NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
• TABLE 132. FINLAND NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 133. FRANCE NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 134. FRANCE NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 135. FRANCE NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
• TABLE 136. FRANCE NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 137. GERMANY NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 138. GERMANY NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 139. GERMANY NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
• TABLE 140. GERMANY NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 141. ISRAEL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 142. ISRAEL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 143. ISRAEL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
• TABLE 144. ISRAEL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 145. ITALY NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 146. ITALY NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 147. ITALY NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
• TABLE 148. ITALY NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 149. NETHERLANDS NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 150. NETHERLANDS NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 151. NETHERLANDS NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
• TABLE 152. NETHERLANDS NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 153. NIGERIA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 154. NIGERIA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 155. NIGERIA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
• TABLE 156. NIGERIA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 157. NORWAY NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 158. NORWAY NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 159. NORWAY NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
• TABLE 160. NORWAY NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 161. POLAND NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 162. POLAND NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 163. POLAND NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
• TABLE 164. POLAND NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 165. QATAR NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 166. QATAR NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 167. QATAR NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
• TABLE 168. QATAR NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 169. RUSSIA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 170. RUSSIA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 171. RUSSIA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
• TABLE 172. RUSSIA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 173. SAUDI ARABIA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 174. SAUDI ARABIA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 175. SAUDI ARABIA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
• TABLE 176. SAUDI ARABIA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 177. SOUTH AFRICA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 178. SOUTH AFRICA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 179. SOUTH AFRICA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
• TABLE 180. SOUTH AFRICA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 181. SPAIN NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 182. SPAIN NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 183. SPAIN NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
• TABLE 184. SPAIN NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 185. SWEDEN NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 186. SWEDEN NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 187. SWEDEN NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
• TABLE 188. SWEDEN NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 189. SWITZERLAND NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 190. SWITZERLAND NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 191. SWITZERLAND NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
• TABLE 192. SWITZERLAND NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 193. TURKEY NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 194. TURKEY NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 195. TURKEY NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
• TABLE 196. TURKEY NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 197. UNITED ARAB EMIRATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 198. UNITED ARAB EMIRATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 199. UNITED ARAB EMIRATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
• TABLE 200. UNITED ARAB EMIRATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 201. UNITED KINGDOM NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 202. UNITED KINGDOM NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 203. UNITED KINGDOM NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
• TABLE 204. UNITED KINGDOM NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 205. NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 206. NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET, FPNV POSITIONING MATRIX, 2023

The Neglected Tropical Diseases Diagnosis Market was valued at USD 6.69 billion in 2023, expected to reach USD 7.04 billion in 2024, and is projected to grow at a CAGR of 5.80%, to USD 9.93 billion by 2030.

Neglected Tropical Diseases (NTDs) include a diverse array of infections affecting over a billion people primarily in tropical and subtropical regions. Defined by their impact on impoverished populations, they significantly hinder economic development and societal progression. The necessity of accurate NTD diagnosis underlies these diseases' ability to cause chronic health issues, debilitating infections, and societal stigma. Applications span from basic diagnostic tools to advanced molecular methodologies, crucial for disease surveillance, effective treatment planning, and transmission reduction. End-use sectors include hospitals, diagnostic laboratories, and research institutions, which utilize these diagnoses to manage outbreaks, guide healthcare policy, and conduct epidemiological studies. Market growth for NTD diagnoses is driven by increased global health funding, heightened awareness, and technological advancements in diagnostic techniques. A growing number of public-private partnerships and global health initiatives emphasize early detection, accurate diagnostics, and cost-effective solutions, presenting opportunities for market expansion. Key growth factors include increased governmental and non-governmental investments, innovation in diagnostic technologies like molecular and point-of-care testing, and expanding access to healthcare in regions burdened by NTDs. However, market challenges include inadequate healthcare infrastructure in endemic regions, limited awareness, regulatory barriers, and the high cost of advanced diagnostic tools. Opportunities exist in developing low-cost, rapid diagnostic tests for NTDs, particularly those deployable in low-resource settings. Innovation can focus on portable and integrated diagnostic platforms that provide quick and accurate results, potentially augmented by digital health technologies for data dissemination and management. To capitalize on these opportunities, companies should focus on strategic collaborations with governments and NGOs, invest in R&D for novel diagnostics, and work towards scalable production techniques. Due diligence must be executed in navigating stringent regulatory environments and addressing healthcare delivery barriers to sustainably grow within this market.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Neglected Tropical Diseases Diagnosis Market

The Neglected Tropical Diseases Diagnosis Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increase in number of programs to tackle neglected tropical diseases
  • Rising prevalence of neglected tropical diseases in tropical and subtropical countries
  • Growing demand for early disease identification
• Market Restraints
  • Lack of neglected tropical diseases treatment awareness in underdeveloped countries
• Market Opportunities
  • Growing development of advanced neglected tropical disease diagnosis devices
  • Rising R&D to develop innovative neglected tropical disease diagnosis
• Market Challenges
  • Lack of standardization tools for diagnosis

Porter's Five Forces: A Strategic Tool for Navigating the Neglected Tropical Diseases Diagnosis Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Neglected Tropical Diseases Diagnosis Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Neglected Tropical Diseases Diagnosis Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Neglected Tropical Diseases Diagnosis Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Neglected Tropical Diseases Diagnosis Market

A detailed market share analysis in the Neglected Tropical Diseases Diagnosis Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Neglected Tropical Diseases Diagnosis Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Neglected Tropical Diseases Diagnosis Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Neglected Tropical Diseases Diagnosis Market

A strategic analysis of the Neglected Tropical Diseases Diagnosis Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Neglected Tropical Diseases Diagnosis Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Bio-Rad Laboratories, Inc., Coris BioConcept SPRL, DiaSys Diagnostic Systems GmbH, F. Hoffmann-La Roche Ltd, Genome Diagnostics Pvt. Ltd., InBios International, Inc., Omega Diagnostics Group PLC, Ortho Clinical Diagnostics, Oscar Medicare Pvt. Ltd., Premier Medical Corporation Ltd., Siemens AG, Thermo Fisher Scientific Inc., and ZeptoMetrix LLC.

Market Segmentation & Coverage

This research report categorizes the Neglected Tropical Diseases Diagnosis Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Service, market is studied across Centralized Service and POC Service.
• Based on Disease, market is studied across African Trypanosomiasis, Buruli Ulcer, Chagas Disease, Chikungunya, Dengue, Dracunculiasis, Echinococcosis, Foodborne Trematodiases, Leishmaniasis, Leprosy, Lymphatic Filariasis, Onchocerciasis, Rabies, Scabies, Schistosomiasis, Snakebite Envenoming, Soil-transmitted Helminth Infections, Taeniasis/Cysticercosis, and Yaws.
• Based on Diagnostic Method, market is studied across Conventional Method and Molecular/Modern Method.
• Based on End-Use, market is studied across Clinical Labs, Home Healthcare, and Hospitals /Clinics.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increase in number of programs to tackle neglected tropical diseases
    • 5.1.1.2. Rising prevalence of neglected tropical diseases in tropical and subtropical countries
    • 5.1.1.3. Growing demand for early disease identification
  • 5.1.2. Restraints
    • 5.1.2.1. Lack of neglected tropical diseases treatment awareness in underdeveloped countries
  • 5.1.3. Opportunities
    • 5.1.3.1. Growing development of advanced neglected tropical disease diagnosis devices
    • 5.1.3.2. Rising R&D to develop innovative neglected tropical disease diagnosis
  • 5.1.4. Challenges
    • 5.1.4.1. Lack of standardization tools for diagnosis
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Neglected Tropical Diseases Diagnosis Market, by Service

• 6.1. Introduction
• 6.2. Centralized Service
• 6.3. POC Service

7. Neglected Tropical Diseases Diagnosis Market, by Disease

• 7.1. Introduction
• 7.2. African Trypanosomiasis
• 7.3. Buruli Ulcer
• 7.4. Chagas Disease
• 7.5. Chikungunya
• 7.6. Dengue
• 7.7. Dracunculiasis
• 7.8. Echinococcosis
• 7.9. Foodborne Trematodiases
• 7.10. Leishmaniasis
• 7.11. Leprosy
• 7.12. Lymphatic Filariasis
• 7.13. Onchocerciasis
• 7.14. Rabies
• 7.15. Scabies
• 7.16. Schistosomiasis
• 7.17. Snakebite Envenoming
• 7.18. Soil-transmitted Helminth Infections
• 7.19. Taeniasis/Cysticercosis
• 7.20. Yaws

8. Neglected Tropical Diseases Diagnosis Market, by Diagnostic Method

• 8.1. Introduction
• 8.2. Conventional Method
• 8.3. Molecular/Modern Method

9. Neglected Tropical Diseases Diagnosis Market, by End-Use

• 9.1. Introduction
• 9.2. Clinical Labs
• 9.3. Home Healthcare
• 9.4. Hospitals /Clinics

10. Americas Neglected Tropical Diseases Diagnosis Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Neglected Tropical Diseases Diagnosis Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Neglected Tropical Diseases Diagnosis Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. Bio-Rad Laboratories, Inc.
• 3. Coris BioConcept SPRL
• 4. DiaSys Diagnostic Systems GmbH
• 5. F. Hoffmann-La Roche Ltd
• 6. Genome Diagnostics Pvt. Ltd.
• 7. InBios International, Inc.
• 8. Omega Diagnostics Group PLC
• 9. Ortho Clinical Diagnostics
• 10. Oscar Medicare Pvt. Ltd.
• 11. Premier Medical Corporation Ltd.
• 12. Siemens AG
• 13. Thermo Fisher Scientific Inc.
• 14. ZeptoMetrix LLC